首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
cholinergic nerve hyperfunction相关文献:
Neurotoxins affecting neuroexocytosis.
Schiavo G, Matteoli M, Montecucco C.
Physiol Rev. 2000 Apr;80(2):717-66. doi: 10.1152/physrev.2000.80.2.717.
PMID:10747206
Entering neurons: botulinum toxins and synaptic vesicle recycling.
Verderio C, Rossetto O, Grumelli C, Frassoni C, Montecucco C, Matteoli M.
EMBO Rep. 2006 Oct;7(10):995-9. doi: 10.1038/sj.embor.7400796.
PMID:17016457
Different mechanism of blockade of neuroexocytosis by presynaptic neurotoxins.
Rossetto O, Rigoni M, Montecucco C.
Toxicol Lett. 2004 Apr 1;149(1-3):91-101. doi: 10.1016/j.toxlet.2003.12.023.
PMID:15093253
Increased Cholinergic Tone Causes Pre-synaptic Neuromuscular Degeneration and is Associated with Impaired Diaphragm Function.
Magalhães-Gomes MPS, Camargos W, Valadão PAC, Garcias RS, Rodrigues HA, Andrade JN, Teixeira VP, Naves LA, Cavalcante WLG, Gallaci M, Guatimosim S, Prado VF, Prado MAM, Guatimosim C.
Neuroscience. 2021 Apr 15;460:31-42. doi: 10.1016/j.neuroscience.2020.12.025. Epub 2021 Feb 4.
PMID:33548369
Tetanus and botulinum neurotoxins: turning bad guys into good by research.
Rossetto O, Seveso M, Caccin P, Schiavo G, Montecucco C.
Toxicon. 2001 Jan;39(1):27-41. doi: 10.1016/s0041-0101(00)00163-x.
PMID:10936621
Action of botulinum neurotoxins in the central nervous system: antiepileptic effects.
Bozzi Y, Costantin L, Antonucci F, Caleo M.
Neurotox Res. 2006 Apr;9(2-3):197-203. doi: 10.1007/BF03033939.
PMID:16785118
Internalization and mechanism of action of clostridial toxins in neurons.
Grumelli C, Verderio C, Pozzi D, Rossetto O, Montecucco C, Matteoli M.
Neurotoxicology. 2005 Oct;26(5):761-7. doi: 10.1016/j.neuro.2004.12.012. Epub 2005 May 31.
PMID:15925409
Revival of the use of botulinum toxin: application in dermatology.
Böni R, Kreyden OP, Burg G.
Dermatology. 2000;200(4):287-91. doi: 10.1159/000018389.
PMID:10894957
Botulinum toxin-physiology and applications in head and neck disorders.
Keir J.
Head Neck. 2005 Jun;27(6):525-35. doi: 10.1002/hed.20247.
PMID:15898076
A novel therapeutic agent, sodium oxybate, improves dystonic symptoms via reduced network-wide activity.
Simonyan K, Frucht SJ, Blitzer A, Sichani AH, Rumbach AF.
Sci Rep. 2018 Oct 31;8(1):16111. doi: 10.1038/s41598-018-34553-x.
PMID:30382161
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3